A clinical Trial in-patients with Dermatomycoses.. Clinical trial is to study efficacy, safety and tolerability of Flutrimazole cream in comparison to Terbinafine Hydrochloride cream (reference product).
Phase 3
Completed
- Conditions
- Health Condition 1: null- DermatomycosesHealth Condition 2: B998- Other infectious disease
- Registration Number
- CTRI/2010/091/000141
- Lead Sponsor
- Ajanta Pharma Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
1. Clinical diagnosis of Dermatomycoses confirmed by laboratory evaluation (microscopic examination confirmed by a positive potassium hydroxide test).
2. Written informed consent by patient.
3. Patient willing to follow up.
Exclusion Criteria
1. Pregnant or nursing females.
2. Patients with severe chronic diseases.
3. Individuals who present a history of hypersensitivity to other antifungal imidazolic, or any of the components of the pharmaceutical form used.
4. Patients who might have required concomitant medication with other antimycotics administered by another route.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method